Treatment of osteoarthritis patients with rofecoxib 12.5 mg and celecoxib 200 mg: A randomized, placebo-controlled trial

被引：0
|
作者：
Ruoff, G
Gilderman, L
Cohen, S
Valenzuela, C
Rodgers, A
Petruschke, R
Terschakovec, A
机构：
[1] Westside Family Med Ctr, Kalamazoo, MI USA
[2] Univ Clin Res, Pembroke Pines, FL USA
[3] Radiant Res, Clin Res, Dallas, TX USA
[4] Merck & Co Inc, W Point, PA USA
来源：
OSTEOARTHRITIS AND CARTILAGE | 2004年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];
学科分类号：
摘要：
引用
收藏
页码：S87 / S88
页数：2
相关论文
共 50 条
  • [1] Comparable efficacy of rofecoxib 12.5 mg and celecoxib 200 mg in the treatment of patients with osteoarthritis: A randomized, controlled trial
    Birbara, C
    Sheldon, E
    Farrell, J
    Rodgers, A
    Petruschke, R
    Robertson, D
    Chang, DJ
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 373 - 374
  • [2] Tolerability of rofecoxib 12.5 mg and celecoxib 200 mg in osteoarthritis patients
    Ruoff, G
    Birbara, C
    Rodgers, A
    Valenzuela, C
    Petruschke, R
    Tershakovec, A
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2004, 12 : S86 - S87
  • [3] Rofecoxib 12.5 mg, rofecoxib 25mg, and celecoxib 200 mg in the treatment of symptomatic osteoarthritis: results of two similarly designed studies
    Smugar, Steven S.
    Schnitzer, Thomas J.
    Weaver, Arthur L.
    Rubin, Bernard R.
    Polis, Adam B.
    Tershakovec, Andrew M.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (07) : 1353 - 1367
  • [4] Efficacy and safety of rofecoxib 12.5 mg and celecoxib 200 mg in two similarly designed osteoarthritis studies
    Birbara, C
    Ruoff, G
    Sheldon, E
    Valenzuela, C
    Rodgers, A
    Petruschke, RA
    Chang, DJ
    Tershakovec, AM
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (01) : 199 - 210
  • [5] Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically-designed, randomized, placebo-controlled studies
    Bingham, C. O.
    Sebba, A. I.
    Rubin, B. R.
    Ruoff, G. E.
    Kremer, J.
    Bird, S.
    Smugar, S. S.
    Fitzgerald, B. J.
    O'Brien, K.
    Tershakovec, A. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 406 - 406
  • [6] Efficacy and safety of rofecoxib 12.5 mg versus nabumetone 1,000 mg in patients with osteoarthritis of the knee: A randomized controlled trial
    Kivitz, AJ
    Greenwald, MW
    Cohen, SB
    Polis, AB
    Najarian, DK
    Dixon, ME
    Moidel, RA
    Green, JA
    Baraf, HSB
    Petruschke, RA
    Matsumoto, AK
    Geba, GP
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (05) : 666 - 674
  • [7] A randomized placebo-controlled trial comparing the efficacy of etoricoxib 30 mg and ibuprofen 2400 mg for the treatment of patients with osteoarthritis
    Puopolo, A.
    Boice, J. A.
    Fidelholtz, J. L.
    Littlejohn, T. W.
    Miranda, P.
    Berrocal, A.
    Ko, A.
    Cichanowitz, N.
    Reicin, A. S.
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2007, 15 (12) : 1348 - 1356
  • [8] Efficacy and safety of etoricoxib 30 mg and celecoxib 200 mg in the treatment of osteoarthritis in two identically designed, randomized, placebo-controlled, non-inferiority studies
    Bingham, C. O., III
    Sebba, A. I.
    Rubin, B. R.
    Ruoff, G. E.
    Kremer, J.
    Bird, S.
    Smugar, S. S.
    Fitzgerald, B. J.
    O'Brien, K.
    Tershakovec, A. M.
    [J]. RHEUMATOLOGY, 2007, 46 (03) : 496 - 507
  • [9] Randomized, placebo-controlled trial of rofecoxib in the acute treatment of migraine
    Silberstein, S
    Tepper, S
    Brandes, J
    Diamond, M
    Goldstein, J
    Winner, P
    Venkatraman, S
    Vrijens, F
    Malbecq, W
    Lines, C
    Visser, WH
    Reines, S
    Yuen, E
    [J]. NEUROLOGY, 2004, 62 (09) : 1552 - 1557
  • [10] Placebo-controlled trial with tolfenamic acid 200 mg and sumatriptan 100 mg in acute treatment of migraine.
    Rasmussen, MJK
    Hansen, AW
    Schmidt-Hansen, PT
    Hansen, PE
    Lademann, A
    Hinge, HH
    [J]. CEPHALALGIA, 1999, 19 (04) : 318 - 319
12345